Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update

Insmed (INSM) Tops Q2 EPS by 5c, Revenues Beat

August 1, 2019 7:54 AM EDT

Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.81), $0.05 better than the analyst estimate of ($0.86). Revenue for the quarter came in at $30 million versus the consensus estimate of $25.76 million.

Second Quarter 2019 Financial Results

Total revenue for the second quarter ended June 30, 2019 was $30.0 million, comprising U.S. net sales of $29.0 million and ex-U.S. net sales of $1.0 million. The ex-U.S. net product sales include $0.9 million from the Temporary Authorization for Use (Autorisation Temporaire d'Utilisation or ATU) program in France and $0.1 million from the named patient program in Germany, both compassionate use programs. Cost of product... More